Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers;inclusion does not imply endorsement by the HBPD INT.

Section editor

Shui-Ying Lei

Email: hbpdje@gmail.com

September

Joint meeting of the 4th Asian-Oceanic Pancreas Association and 2011 annual congress of the Korean Pancreatobiliary Association September 2-3, 2011; Jeju, Korea

Sponsored by the Asian-Oceanic Pancreatic Association (AOPA), the AOPA meeting 2011 will be held on September 2-3, 2011 in Jeju, Korea. The goal of the AOPA meeting is to present cutting edge information and latest advances on clinical and basic research in pancreatic diseases. For more information, please contact: Secretariat, Tel: +82-2-2269-4381; Fax: +82-2-2269-4380; Email: aopa2011@ conventionpm.com. Website: www.aopa2011.org.

International congress of endoscopy 2011 September 10-14, 2011; Los Angeles, USA

This meeting will bring surgical endoscopists and medical endoscopists along with their nursing staffs to work side by side to present not only the techniques of performing the procedures but also discuss the wide scope of surgical and medical endoscopic alternatives for management of varied gastrointestinal diseases. The focus will be on different facets of surgical and medical endoscopy including management/avoidance of complications, emerging technologies, and innovative uses of existing technologies that cross boundaries between these groups. There are planned meetings, symposia, state of the art lectures and multiple live sessions by experts from various parts of the world, who will telecast advances in endoscopy, advances in surgery, and the state of combined approaches to gastrointestinal diseases. If you have any questions regarding registration, please contact: Tel: +49-300-6690; Fax: +49-30-305-73-91; Email: ice2011@cpo-hanser.de. Website: http://www.ice2011.com.

6th national congress on severe liver disease September 14-17, 2011; Lanzhou, China

The topics of this congress include severe hepatitis and liver failure, chronic hepatitis, liver fibrosis and cirrhosis, hepatocellular carcinoma and liver transplantation, artificial liver and blood purification, genetic and metabolic liver disease, drug-induced and alcohol liver disease, parasite liver disease, cellular and immune therapy for liver disease, pregnancy related and baby liver disease, miscellaneous and others. For any further information, please refer to: Dr. Hao Cheng, or Hai-Yang Zhou, Tel: 86-10-63051066, or 63058120; Fax: 86-10-63051016; Email: office@cnsld.org. Website: http://www.cnsld.org.

7th national annual conference on the advanced tumor in the digestive system September 16-18, 2011; Jinan, China

Hosted by Gastric Disease Committee, CPAM and the Jinan Military General Hospital, the 7th national annual conference on the advanced tumor in the digestive system is to be held on September 16-18, 2011 at Jinan, China. Topics include the clinical research, basic research, pathogenesis, prevention strategies, diagnosis and treatment of the advanced tumor in the digestive system (esophagus, duodenum cancer, gastric cancer, intestinal cancer, colorectal cancer, hepatobiliary and pancreatic cancer, peritoneal carcinoma). The literature review, clinical experience, clinical summary, case reports are also welcome. For any further information, please contact: Zhi Wei, Department of Gastroenterology, Jinan Military General Hospital, 25 Shifan Road, Jinan 250031, China. Mobile phone: 86-13969156983; Email: xiaohuahuiyi@126. com.

October

Translation of the cancer genome: scientific, clinical, and operational challenges October 15-18, 2011; Hyatt Regency San Francisco, San Francisco, CA, USA

This conference will bring together basic, translational, and clinical scientists from academia and the pharmaceutical industry to discuss and outline effective scientific, clinical, and operational approaches to translate genome discovery to effective biomarkers and therapies. Conference cochairpersons: Lynda Chin, Dana-Farber Cancer Institute, Boston, MA; Joe W. Gray, Lawrence Berkeley National Laboratory, Berkeley, CA; William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA. For more information, please visit website: http://www. aacr.org/home/scientists/meetings--workshops/specialconferences/translation-of-the-cancer-genome.aspx.

Metabolism and cancer October 16-19, 2011; Sheraton Inner Harbor Hotel, Baltimore, MD, USA

The conference co-chairpersons are Sally Kornbluth, Duke University, Durham, NC, Nickolas Papadopoulos, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, M. Celeste Simon, University of Pennsylvania, Philadelphia, PA. This conference will focus on the basic biology as well as the development of targeted therapeutics that capitalize on our understanding of key intervention points in metabolic and growth control pathways. Poster sessions are scheduled to allow investigators to present and discuss their latest research, and with an expected attendance of more than 300 people, this will provide networking and collaboration-building opportunities that wouldn't be possible without this dynamic forum. Website: http:// www.aacr.org/home/scientists/meetings--workshops/ special-conferences/metabolism-and-cancer.aspx.

November

Postgraduate course: cirrhosis: current challenges and future directions November 4-5, 2011; San Francisco, CA, Moscone West, USA

The course directors are Guadalupe Garcia-Tsao, MD and Patrick S. Kamath, MD. The goals and objectives are to describe the natural history of cirrhosis; distinguish between compensated from a decompensated patients; identify the main complications that define decompensation; identify risk strata for patients presenting with each of the complications of cirrhosis; and explain how to manage patients according to each risk strata. For more information, please visit: http://www.aasld.org/ lm2011/program/Pages/PostGraduateCourse.aspx.

The liver meeting 2011—the 62nd annual meeting of the American Association for the Study of Liver Diseases November 4-8, 2011; San Francisco, CA, Moscone West, USA

For more information, please visit: https://www.aasld.org/ LM2011/Pages/default.aspx.

Molecular targets and cancer therapeutics November 12-16, 2011; Moscone Center West, San Francisco, California, USA

This major conference brings together academics, scientists, and representatives from the pharmaceutical industry to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular biology. During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development, and the execution of large, prospective, randomized, multicenter cancer clinical trials. Together, the level of excitement surrounding targeted therapy and the high caliber of the science presented fuel the power of this meeting to attract the world's leaders in the development of new cancer therapeutics. The deadline for abstract submission is September 12, 2011. Website: http://www.aacr.org/home/ scientists/meetings--workshops/molecular-targets-andcancer-therapeutics.aspx.

December

New horizons in cancer research: biology to prevention to therapy December 13-16, 2011; The Leela Kempinski Gurgaon, Delhi, India

The chairperson of this conference is Prof. Anil K. Rustgi, University of Pennsylvania, Philadelphia, PA, USA. A large, broadly focused meeting, New Horizons in cancer research: biology to prevention to therapy will center on translational cancer research, drawing on the latest trends and discoveries in the early detection, prevention, and treatment of cancer. The conference will be structured to appeal to a broad spectrum of cancer researchers and clinicians. A robust program is being developed, which will provide significant value to those attending the conference. Conference attendance will be drawn from the academic research and clinical community, as well as industry. As such, New Horizons in cancer research will serve as a dynamic platform for the advancement of cancer science and care, and for the establishment of new collaborations on an international scale. For more information, please visit website: http://www.aacr.org/home/scientists/meetings--workshops/new-horizons-in-cancer-research. aspx.